Cosmo Bio Co., Ltd. (3386) Earnings Report: Operating Income Up 1.2% YoY to 279 Million Yen, Net Income Increases 10.5%

Cosmo Bio Co., Ltd. (3386) has released its financial results, reporting net sales of 5,914 million yen (a 9.5% increase year-over-year), operating income of 279 million yen (a 1.2% increase), ordinary income of 340 million yen (a 0.8% decrease), and net income attributable to owners of the parent of 277 million yen (a 10.5% increase). The company maintained a top-line expansion trend, achieving double-digit growth in final profit. Regarding its financial and cash flow position, the company secured 3.468 billion yen in cash and cash equivalents as of June 30, 2026, with operating cash flow at 0.72 billion yen and free cash flow at 0.86 billion yen, demonstrating robust cash-generating capabilities. Furthermore, Return on Equity (ROE) stands at 4.38%, Return on Assets (ROA) at 2.66%, and EBITDA at 370 million yen, supporting a stable and sound financial foundation for ongoing business operations.

---

Correction (September 19, 2026)：The affected figures and reporting-period labels were corrected after checking the source disclosure. Source disclosure